Attached files

file filename
EX-23.01 - EXHIBIT 23.01 - Tonix Pharmaceuticals Holding Corp.v402310_ex23-01.htm
EX-21.01 - EXHIBIT 21.01 - Tonix Pharmaceuticals Holding Corp.v402310_ex21-01.htm
EX-10.16 - EXHIBIT 10.16 - Tonix Pharmaceuticals Holding Corp.v402310_ex10-16.htm
EX-31.01 - EXHIBIT 31.01 - Tonix Pharmaceuticals Holding Corp.v402310_ex31-01.htm
EXCEL - IDEA: XBRL DOCUMENT - Tonix Pharmaceuticals Holding Corp.Financial_Report.xls
10-K - FORM 10-K - Tonix Pharmaceuticals Holding Corp.v402310_10k.htm
EX-31.02 - EXHIBIT 31.02 - Tonix Pharmaceuticals Holding Corp.v402310_ex31-02.htm

 

Exhibit 32.01

 

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Seth Lederman, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Tonix Pharmaceuticals Holding Corp. on Form 10-K for the fiscal year ended December 31, 2014 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of Tonix Pharmaceuticals Holding Corp.

 

    By:  

/s/ SETH LEDERMAN

Date: February 27, 2015   Name:   Seth Lederman
    Title:   Chief Executive Officer

 

I, Leland Gershell, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Tonix Pharmaceuticals Holding Corp. on Form 10-K for the fiscal year ended December 31, 2014 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of Tonix Pharmaceuticals Holding Corp.

 

    By:  

/s/ LELAND GERSHELL

Date: February 27, 2015   Name:   Leland Gershell
    Title:   Chief Financial Officer